Optic Neuritis Recovery After Oral or IV Corticosteroids
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Patients aged 18-65 with acute demyelinating optic neuritis where treatment with high dose
corticosteroids are already been chosen by the patient and the diagnosing physician will be
contacted for screening and enrollment. Patients will then be randomized to receive
equivalent doses of either intravenous (IV) or oral corticosteroid treatment. Optic nerve
function assessments will be compared at baseline, prior to treatment, one and six months
post corticosteroid treatment. This will allow for a comparison on whether the route of
medication plays a role in the effectiveness of treatment with high dose corticosteroids.